Hemifacial Spasm vs. Blepharospasm: Key Clinical Distinctions
Hemifacial spasm and blepharospasm are fundamentally different disorders: hemifacial spasm is a unilateral, involuntary twitching caused by peripheral facial nerve compression (typically by vascular loops), while blepharospasm is a bilateral dystonic disorder of central origin affecting primarily the eyelids.
Distribution and Laterality
Hemifacial spasm (HFS):
- Strictly unilateral involvement of facial muscles
- Affects all muscles innervated by the facial nerve on one side
- Typically begins around the eye and spreads downward to involve the lower face
- Most commonly affects the left side (66.7% in one cohort) 1
Blepharospasm (BEB):
- Bilateral eyelid involvement
- Primarily affects the orbicularis oculi muscles
- May be part of Meige syndrome when associated with lower facial and jaw dystonia
- Does not spread beyond the facial region 2, 3
Underlying Pathophysiology
The pathophysiologic mechanisms are entirely distinct, which is critical for understanding treatment approaches:
HFS:
- Caused by neurovascular compression of the facial nerve at its exit from the brainstem 4
- Peripheral nerve disorder with demonstrable structural cause
- MRI with 3-D heavily T2-weighted sequences and MRA can identify vascular loops compressing the centrally myelinated portion of the facial nerve with >95% sensitivity 4
- Surgical microvascular decompression is a definitive treatment option
BEB:
- Central nervous system disorder involving maladaptation in multiple brain regions 5
- Part of the cranial dystonia spectrum
- No identifiable structural lesion on imaging
- Thought to involve dysfunction of brainstem blink reflex circuitry 1
Clinical Presentation Patterns
HFS:
- Intermittent, spasmodic contractions that are brief and irregular 3
- Twitching movements that patients cannot control
- Usually presents in the third or fourth decade of life 3
- Less functionally disabling but causes significant distress and embarrassment 2
BEB:
- Sustained, forceful eyelid closure episodes
- Uncontrollable squeezing movements
- Typically presents in the fifth and sixth decades of life 3
- Can result in functional blindness despite normal visual pathways 3
- Particularly debilitating due to inability to keep eyes open 6
Important Clinical Overlap
A critical caveat: 5.5% of HFS patients develop coexistent BEB 1, significantly higher than the general population (0%). This typically occurs:
- Mean of 0.8 years after HFS onset (66.7% of cases) 1
- Suggests changes in brainstem blink reflex circuitry may play a modulatory role in at-risk individuals 1
- Both conditions show altered functional connectivity between the anterior cerebellar network and left occipital regions 5
Diagnostic Approach
For HFS:
- Clinical diagnosis based on unilateral involvement
- MRI head with 3-D heavily T2-weighted sequences and MRA to identify neurovascular compression 4
- Imaging correlates well with surgical findings (>95% accuracy) 4
For BEB:
- Clinical diagnosis based on bilateral eyelid involvement
- Imaging typically not indicated unless atypical features present
- Rule out secondary causes: medications, ocular surface disease, neurologic conditions 6
Treatment Implications
Both conditions respond to botulinum toxin injections, but the approach differs:
HFS:
- Botulinum toxin is first-line treatment
- Microvascular decompression surgery is curative option when vascular compression confirmed 4
- Pretarsal injection technique shows superior outcomes 7
BEB:
- Botulinum toxin is primary treatment (surgical options largely supplanted) 3
- Pretarsal technique demonstrates better JRS scores and fewer adverse events 7
- Chronic condition requiring lifelong management in 95% of cases 8
Prognosis
Spontaneous resolution is rare but possible: approximately 5% of both HFS and BEB patients may experience long-term resolution, though predictors remain unknown 8. Both conditions are typically lifelong, requiring ongoing management.